Suggests aspirin research for cancer

COURTESY TO THE BELLINGHAM HERALDJuly 9, 2014 

Thank you for your article "Study: Aspirin cuts the risk of pancreatic cancer by half." This is important news which deserves the widest possible dissemination. I hope your readers will take it very seriously.

I volunteer with several ovarian cancer research programs and, although completely lacking a biology background, I have been reading as much cancer-related literature as I can find and understand for the last two years. I have run on reports of a number of clinical trials that demonstrate - to me, persuasively - that aspirin somehow lowers the risk of acquiring various types of cancer. I write a blog about my often-comical efforts to help out in a field I know next to nothing about. The aspirin-cancer link has come up several times.

In my opinion, it is all but certain that aspirin is a potent cancer-fighting drug. It also is cheap, ubiquitous and easy to administer. Yes, it has its serious side effects, as your article describes, so nobody should simply rush to the drug store and begin gulping down fistfuls of aspirin without first consulting a physician. On the other hand, I hope that research findings such as these begin to diffuse into clinical practice more swiftly than has sometimes been the case.

Myrl Beck

Bellingham

Bellingham Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service